203 related articles for article (PubMed ID: 33753741)
1. Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy.
Weinhofer I; Rommer P; Zierfuss B; Altmann P; Foiani M; Heslegrave A; Zetterberg H; Gleiss A; Musolino PL; Gong Y; Forss-Petter S; Berger T; Eichler F; Aubourg P; Köhler W; Berger J
Nat Commun; 2021 Mar; 12(1):1816. PubMed ID: 33753741
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy.
Wang H; Davison MD; Kramer ML; Qiu W; Gladysheva T; Chiang RMS; Kayatekin C; Nascene DR; Taghizadeh LA; King CJ; Nolan EE; Gupta AO; Orchard PJ; Lund TC
Cells; 2022 Mar; 11(5):. PubMed ID: 35269535
[TBL] [Abstract][Full Text] [Related]
3. Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy.
Weinhofer I; Rommer P; Gleiss A; Ponleitner M; Zierfuss B; Waidhofer-Söllner P; Fourcade S; Grabmeier-Pfistershammer K; Reinert MC; Göpfert J; Heine A; Yska HAF; Casasnovas C; Cantarín V; Bergner CG; Mallack E; Forss-Petter S; Aubourg P; Bley A; Engelen M; Eichler F; Lund TC; Pujol A; Köhler W; Kühl JS; Berger J
EBioMedicine; 2023 Oct; 96():104781. PubMed ID: 37683329
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy.
Shah N; Singh I
Mol Neurobiol; 2017 Mar; 54(2):1392-1403. PubMed ID: 26843114
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy.
Kakumoto T; Matsukawa T; Ishiura H; Mori H; Tsuji S; Toda T
Ann Clin Transl Neurol; 2023 Jul; 10(7):1230-1238. PubMed ID: 37259474
[TBL] [Abstract][Full Text] [Related]
6. Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy.
van Ballegoij WJC; van de Stadt SIW; Huffnagel IC; Kemp S; Willemse EAJ; Teunissen CE; Engelen M
Ann Clin Transl Neurol; 2020 Nov; 7(11):2127-2136. PubMed ID: 33047897
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.
Turk BR; Theisen BE; Nemeth CL; Marx JS; Shi X; Rosen M; Jones RO; Moser AB; Watkins PA; Raymond GV; Tiffany C; Fatemi A
JAMA Neurol; 2017 May; 74(5):519-524. PubMed ID: 28288261
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
[TBL] [Abstract][Full Text] [Related]
9. Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy.
Baarine M; Khan M; Singh A; Singh I
PLoS One; 2015; 10(11):e0143238. PubMed ID: 26581106
[TBL] [Abstract][Full Text] [Related]
10. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.
Schlüter A; Espinosa L; Fourcade S; Galino J; López E; Ilieva E; Morató L; Asheuer M; Cook T; McLaren A; Reid J; Kelly F; Bates S; Aubourg P; Galea E; Pujol A
Hum Mol Genet; 2012 Mar; 21(5):1062-77. PubMed ID: 22095690
[TBL] [Abstract][Full Text] [Related]
11. Seven-Tesla proton magnetic resonance spectroscopic imaging in adult X-linked adrenoleukodystrophy.
Ratai E; Kok T; Wiggins C; Wiggins G; Grant E; Gagoski B; O'Neill G; Adalsteinsson E; Eichler F
Arch Neurol; 2008 Nov; 65(11):1488-94. PubMed ID: 19001168
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia.
Veenhuis SJG; Gupta AS; de Gusmão CM; Thornton J; Margus B; Rothblum-Oviatt C; Otto M; Halbgebauer S; van Os NJH; van de Warrenburg BPC; Verbeek MM; Willemsen MAAP
Eur J Paediatr Neurol; 2021 May; 32():93-97. PubMed ID: 33878608
[TBL] [Abstract][Full Text] [Related]
13. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F
Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament light chain and MRI volume parameters as markers of neurodegeneration in multiple sclerosis.
Filippi P; Vestenická V; Siarnik P; Sivakova M; Čopíková-Cudráková D; Belan V; Hanes J; Novák M; Kollar B; Turcani P
Neuro Endocrinol Lett; 2020 Apr; 41(1):17-26. PubMed ID: 32338853
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study.
van Geel BM; Poll-The BT; Verrips A; Boelens JJ; Kemp S; Engelen M
J Inherit Metab Dis; 2015 Mar; 38(2):359-61. PubMed ID: 25488625
[TBL] [Abstract][Full Text] [Related]
16. Neurofilament light chain in cerebrospinal fluid or blood as a biomarker for mild cognitive impairment: A systematic review and meta-analysis.
Zhang J; Cheng H; Liu W; Li H; Song Y; Jia L
Medicine (Baltimore); 2022 Mar; 101(9):e28932. PubMed ID: 35244049
[TBL] [Abstract][Full Text] [Related]
17. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C
Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
[TBL] [Abstract][Full Text] [Related]
18. The clinical spectrum of X-linked adrenoleukodystrophy: from Addison's-only in men to middle-age neurologic manifestations in women.
Fadiga L; Melo M; Saraiva J; Paiva I
Hormones (Athens); 2022 Mar; 21(1):33-40. PubMed ID: 34652632
[TBL] [Abstract][Full Text] [Related]
19. Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia.
Donath H; Woelke S; Schubert R; Kieslich M; Theis M; Auburger G; Duecker RP; Zielen S
Cerebellum; 2022 Feb; 21(1):39-47. PubMed ID: 33893614
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy.
Taghizadeh LA; King CJ; Nascene DR; Gupta AO; Orchard PJ; Higgins L; Markowski TW; Nolan EE; Furcich JW; Lund TC
Sci Rep; 2022 May; 12(1):7985. PubMed ID: 35568699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
